Preadmission usage of metformin and mortality in COVID-19 patients including the post-discharge period

DOI record: { "DOI": "10.1007/s11845-021-02823-9", "ISSN": [ "0021-1265", "1863-4362" ], "URL": "http://dx.doi.org/10.1007/s11845-021-02823-9", "alternative-id": [ "2823" ], "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "24 September 2021" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "21 October 2021" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 3, "value": "29 October 2021" }, { "group": { "label": "Declarations", "name": "EthicsHeading" }, "name": "Ethics", "order": 1 }, { "group": { "label": "Ethics approval", "name": "EthicsHeading" }, "name": "Ethics", "order": 2, "value": "The study was approved by the Local Ethics Committee of the Canakkale Onsekiz Mart University Medical School (2011-KAEK-27/2021-E.2100041806)." }, { "group": { "label": "Conflict of interest", "name": "EthicsHeading" }, "name": "Ethics", "order": 3, "value": "The authors declare no competing interests." }, { "label": "Free to read", "name": "free", "value": "This content has been made available to all." } ], "author": [ { "ORCID": "http://orcid.org/0000-0003-0022-5704", "affiliation": [], "authenticated-orcid": false, "family": "Saygili", "given": "Emre Sedar", "sequence": "first" }, { "affiliation": [], "family": "Karakiliç", "given": "Ersen", "sequence": "additional" }, { "affiliation": [], "family": "Mert", "given": "Erdal", "sequence": "additional" }, { "affiliation": [], "family": "Şener", "given": "Alper", "sequence": "additional" }, { "affiliation": [], "family": "Mirci", "given": "Arzu", "sequence": "additional" } ], "container-title": [ "Irish Journal of Medical Science (1971 -)" ], "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2021, 10, 29 ] ], "date-time": "2021-10-29T01:02:19Z", "timestamp": 1635469339000 }, "deposited": { "date-parts": [ [ 2021, 10, 29 ] ], "date-time": "2021-10-29T02:12:11Z", "timestamp": 1635473531000 }, "indexed": { "date-parts": [ [ 2021, 12, 15 ] ], "date-time": "2021-12-15T23:06:30Z", "timestamp": 1639609590292 }, "is-referenced-by-count": 0, "issn-type": [ { "type": "print", "value": "0021-1265" }, { "type": "electronic", "value": "1863-4362" } ], "issued": { "date-parts": [ [ 2021, 10, 29 ] ] }, "language": "en", "license": [ { "URL": "https://www.springer.com/tdm", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 10, 29 ] ], "date-time": "2021-10-29T00:00:00Z", "timestamp": 1635465600000 } }, { "URL": "https://www.springer.com/tdm", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 10, 29 ] ], "date-time": "2021-10-29T00:00:00Z", "timestamp": 1635465600000 } } ], "link": [ { "URL": "https://link.springer.com/content/pdf/10.1007/s11845-021-02823-9.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/article/10.1007/s11845-021-02823-9/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/content/pdf/10.1007/s11845-021-02823-9.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "prefix": "10.1007", "published": { "date-parts": [ [ 2021, 10, 29 ] ] }, "published-online": { "date-parts": [ [ 2021, 10, 29 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "DOI": "10.1016/S2213-8587(20)30238-2", "author": "M Apicella", "doi-asserted-by": "publisher", "first-page": "782", "journal-title": "Lancet Diabetes Endocrinol", "key": "2823_CR1", "unstructured": "Apicella M, Campopiano MC, Mantuano M et al (2020) COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol 8:782–792. https://doi.org/10.1016/S2213-8587(20)30238-2", "volume": "8", "year": "2020" }, { "DOI": "10.1016/S2213-8587(20)30272-2", "author": "E Barron", "doi-asserted-by": "publisher", "first-page": "813", "journal-title": "Lancet Diabetes Endocrinol", "key": "2823_CR2", "unstructured": "Barron E, Bakhai C, Kar P et al (2020) Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol 8:813–822. https://doi.org/10.1016/S2213-8587(20)30272-2", "volume": "8", "year": "2020" }, { "DOI": "10.1002/dmrr.3319", "author": "W Guo", "doi-asserted-by": "publisher", "journal-title": "Diabetes Metab Res Rev", "key": "2823_CR3", "unstructured": "Guo W, Li M, Dong Y et al (2020) Diabetes is a risk factor for the progression and prognosis of COVID -19. Diabetes Metab Res Rev 36:e3319. https://doi.org/10.1002/dmrr.3319", "volume": "36", "year": "2020" }, { "DOI": "10.4049/jimmunol.1700474", "author": "C Kajiwara", "doi-asserted-by": "publisher", "first-page": "623", "journal-title": "J Immunol", "key": "2823_CR4", "unstructured": "Kajiwara C, Kusaka Y, Kimura S et al (2018) Metformin mediates protection against Legionella pneumonia through activation of AMPK and mitochondrial reactive oxygen species. J Immunol 200:623–631. https://doi.org/10.4049/jimmunol.1700474", "volume": "200", "year": "2018" }, { "DOI": "10.4103/0366-6999.223856", "author": "Y Chen", "doi-asserted-by": "publisher", "first-page": "376", "journal-title": "Chin Med J (Engl)", "key": "2823_CR5", "unstructured": "Chen Y, Gu F, Guan J-L (2018) Metformin might inhibit virus through increasing insulin sensitivity. Chin Med J (Engl) 131:376–377. https://doi.org/10.4103/0366-6999.223856", "volume": "131", "year": "2018" }, { "DOI": "10.1007/s00125-017-4318-z", "author": "CJ Bailey", "doi-asserted-by": "publisher", "first-page": "1566", "journal-title": "Diabetologia", "key": "2823_CR6", "unstructured": "Bailey CJ (2017) Metformin: historical overview. Diabetologia 60:1566–1576. https://doi.org/10.1007/s00125-017-4318-z", "volume": "60", "year": "2017" }, { "DOI": "10.1186/s12931-019-1035-9", "doi-asserted-by": "publisher", "key": "2823_CR7", "unstructured": "Ho TW,Huang CT, Tsai YJ et al (2019) Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease Respir Res 20https://doi.org/10.1186/s12931-019-1035-9" }, { "DOI": "10.1513/AnnalsATS.201812-897OC", "author": "TD Wu", "doi-asserted-by": "publisher", "first-page": "1527", "journal-title": "Ann Am Thorac Soc", "key": "2823_CR8", "unstructured": "Wu TD, Keet CA, Fawzy A et al (2019) Association of metformin initiation and risk of asthma exacerbation A claims-based cohort study. Ann Am Thorac Soc 16:1527–1533. https://doi.org/10.1513/AnnalsATS.201812-897OC", "volume": "16", "year": "2019" }, { "DOI": "10.1183/13993003.congress-2018.PA2639", "doi-asserted-by": "crossref", "key": "2823_CR9", "unstructured": "Mortensen E, Anzueto A (2018) Association of metformin and mortality for patients with diabetes who are hospitalised with pneumonia. In: Respiratory infections. European Respiratory Society, p PA2639" }, { "DOI": "10.1007/s00228-019-02786-y", "author": "M Zhang", "doi-asserted-by": "publisher", "first-page": "149", "journal-title": "Eur J Clin Pharmacol", "key": "2823_CR10", "unstructured": "Zhang M, He J (2020) Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis. Eur J Clin Pharmacol 76:149–159. https://doi.org/10.1007/s00228-019-02786-y", "volume": "76", "year": "2020" }, { "DOI": "10.1111/resp.13486", "author": "A Mendy", "doi-asserted-by": "publisher", "first-page": "646", "journal-title": "Respirology", "key": "2823_CR11", "unstructured": "Mendy A, Gopal R, Alcorn JF, Forno E (2019) Reduced mortality from lower respiratory tract disease in adult diabetic patients treated with metformin. Respirology 24:646–651. https://doi.org/10.1111/resp.13486", "volume": "24", "year": "2019" }, { "DOI": "10.1186/s13054-019-2346-4", "author": "H Liang", "doi-asserted-by": "publisher", "first-page": "50", "journal-title": "Crit Care", "key": "2823_CR12", "unstructured": "Liang H, Ding X, Li L et al (2019) Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies. Crit Care 23:50. https://doi.org/10.1186/s13054-019-2346-4", "volume": "23", "year": "2019" }, { "DOI": "10.1016/S2213-8587(21)00050-4", "author": "K Khunti", "doi-asserted-by": "publisher", "first-page": "293", "journal-title": "Lancet Diabetes Endocrinol", "key": "2823_CR13", "unstructured": "Khunti K, Knighton P, Zaccardi F et al (2021) Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes Endocrinol 9:293–303. https://doi.org/10.1016/S2213-8587(21)00050-4", "volume": "9", "year": "2021" }, { "DOI": "10.1016/j.obmed.2020.100290", "author": "TI Hariyanto", "doi-asserted-by": "publisher", "journal-title": "Obes Med", "key": "2823_CR14", "unstructured": "Hariyanto TI, Kurniawan A (2020) Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection. Obes Med 19:100290. https://doi.org/10.1016/j.obmed.2020.100290", "volume": "19", "year": "2020" }, { "DOI": "10.1002/jmv.26498", "author": "CS Kow", "doi-asserted-by": "publisher", "first-page": "695", "journal-title": "J Med Virol", "key": "2823_CR15", "unstructured": "Kow CS, Hasan SS (2021) Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: a meta-analysis. J Med Virol 93:695–697. https://doi.org/10.1002/jmv.26498", "volume": "93", "year": "2021" }, { "DOI": "10.1001/jama.2020.21465", "author": "JP Donnelly", "doi-asserted-by": "publisher", "first-page": "304", "journal-title": "JAMA", "key": "2823_CR16", "unstructured": "Donnelly JP, Wang XQ, Iwashyna TJ, Prescott HC (2021) Readmission and death after initial hospital discharge among patients with COVID-19 in a large multihospital system. JAMA 325:304. https://doi.org/10.1001/jama.2020.21465", "volume": "325", "year": "2021" }, { "DOI": "10.1136/bmj.n693", "doi-asserted-by": "publisher", "key": "2823_CR17", "unstructured": "Ayoubkhani D, Khunti K, Nafilyan V et al (2021) Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ 372 https://doi.org/10.1136/bmj.n693" }, { "DOI": "10.1016/j.diabet.2020.10.006", "doi-asserted-by": "publisher", "key": "2823_CR18", "unstructured": "Do JY, Kim SW, Park JW et al (2020) Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19? Diabetes Metab 101208https://doi.org/10.1016/j.diabet.2020.10.006" }, { "DOI": "10.3389/fendo.2021.645194", "doi-asserted-by": "publisher", "key": "2823_CR19", "unstructured": "Zangiabadian M, Nejadghaderi SA, Zahmatkesh MM et al (2021) The efficacy and potential mechanisms of metformin in the treatment of COVID-19 in the diabetics: a systematic review Front Endocrinol (Lausanne) 12 https://doi.org/10.3389/fendo.2021.645194" }, { "DOI": "10.1016/j.cmet.2020.08.013", "author": "X Cheng", "doi-asserted-by": "publisher", "first-page": "537", "journal-title": "Cell Metab", "key": "2823_CR20", "unstructured": "Cheng X, Liu Y-M, Li H et al (2020) Metformin is associated with higher incidence of acidosis, but not mortalitY, in individuals with COVID-19 and pre-existing type 2 diabetes. Cell Metab 32:537-547.e3. https://doi.org/10.1016/j.cmet.2020.08.013", "volume": "32", "year": "2020" }, { "DOI": "10.7326/0003-4819-150-9-200905050-00006", "author": "AS Levey", "doi-asserted-by": "publisher", "first-page": "604", "journal-title": "Ann Intern Med", "key": "2823_CR21", "unstructured": "Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006", "volume": "150", "year": "2009" }, { "DOI": "10.1016/j.diabres.2020.108151", "author": "A Ceriello", "doi-asserted-by": "publisher", "journal-title": "Diabetes Res Clin Pract", "key": "2823_CR22", "unstructured": "Ceriello A, Stoian AP, Rizzo M (2020) COVID-19 and diabetes management: what should be considered? Diabetes Res Clin Pract 163:108151. https://doi.org/10.1016/j.diabres.2020.108151", "volume": "163", "year": "2020" }, { "DOI": "10.1007/s00592-021-01739-1", "author": "A Avogaro", "doi-asserted-by": "publisher", "journal-title": "Acta Diabetol", "key": "2823_CR23", "unstructured": "Avogaro A, Bonora B, Fadini GP (2021) Managing diabetes in diabetic patients with COVID: where do we start from? Acta Diabetol. https://doi.org/10.1007/s00592-021-01739-1", "year": "2021" }, { "DOI": "10.1016/j.dsx.2020.11.006", "author": "AA Lukito", "doi-asserted-by": "publisher", "first-page": "2177", "journal-title": "Diabetes Metab Syndr Clin Res Rev", "key": "2823_CR24", "unstructured": "Lukito AA, Pranata R, Henrina J et al (2020) The effect of metformin consumption on mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. Diabetes Metab Syndr Clin Res Rev 14:2177–2183. https://doi.org/10.1016/j.dsx.2020.11.006", "volume": "14", "year": "2020" }, { "DOI": "10.1016/j.diabres.2021.108925", "doi-asserted-by": "publisher", "key": "2823_CR25", "unstructured": "Dave JA, Tamuhla T, Tiffin N et al (2021) Risk factors for COVID-19 hospitalisation and death in people living with diabetes: a virtual cohort study from the Western Cape Province South Africa Diabetes Res Clin Pract 108925 https://doi.org/10.1016/j.diabres.2021.108925" }, { "DOI": "10.4269/ajtmh.20-0375", "author": "P Luo", "doi-asserted-by": "publisher", "first-page": "69", "journal-title": "Am J Trop Med Hyg", "key": "2823_CR26", "unstructured": "Luo P, Qiu L, Liu Y et al (2020) Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis. Am J Trop Med Hyg 103:69–72. https://doi.org/10.4269/ajtmh.20-0375", "volume": "103", "year": "2020" }, { "DOI": "10.1016/j.dsx.2021.02.022", "author": "R Ghany", "doi-asserted-by": "publisher", "first-page": "513", "journal-title": "Diabetes Metab Syndr Clin Res Rev", "key": "2823_CR27", "unstructured": "Ghany R, Palacio A, Dawkins E et al (2021) Metformin is associated with lower hospitalisations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA. Diabetes Metab Syndr Clin Res Rev 15:513–518. https://doi.org/10.1016/j.dsx.2021.02.022", "volume": "15", "year": "2021" }, { "DOI": "10.2337/dc20-0660", "author": "Y Chen", "doi-asserted-by": "publisher", "first-page": "1399", "journal-title": "Diabetes Care", "key": "2823_CR28", "unstructured": "Chen Y, Yang D, Cheng B et al (2020) Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care 43:1399–1407. https://doi.org/10.2337/dc20-0660", "volume": "43", "year": "2020" }, { "DOI": "10.1210/clinem/dgab067", "author": "J Wang", "doi-asserted-by": "publisher", "first-page": "1255", "journal-title": "J Clin Endocrinol Metab", "key": "2823_CR29", "unstructured": "Wang J, Cooper JM, Gokhale K et al (2021) Association of metformin with susceptibility to COVID-19 in people with type 2 diabetes. J Clin Endocrinol Metab 106:1255–1268. https://doi.org/10.1210/clinem/dgab067", "volume": "106", "year": "2021" }, { "DOI": "10.1016/j.aohep.2021.100553", "doi-asserted-by": "publisher", "key": "2823_CR30", "unstructured": "Salık F, Uzundere O, Bıçak M et al (2021) Liver function as a predictor of mortality in COVID-19 Retrospective study Ann Hepatol 100553https://doi.org/10.1016/j.aohep.2021.100553" }, { "DOI": "10.1016/j.aohep.2020.08.068", "doi-asserted-by": "publisher", "key": "2823_CR31", "unstructured": "Medetalibeyoglu A, Catma Y, Senkal N et al (2019) The effect of liver test abnormalities on the prognosis of COVID-19. Ann Hepatol 19:614–621. https://doi.org/10.1016/j.aohep.2020.08.068" } ], "reference-count": 31, "references-count": 31, "relation": {}, "score": 1, "short-container-title": [ "Ir J Med Sci" ], "short-title": [], "source": "Crossref", "subject": [ "General Medicine" ], "subtitle": [], "title": [ "Preadmission usage of metformin and mortality in COVID-19 patients including the post-discharge period" ], "type": "journal-article", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy" }